The Children's Vaccine Initiative: Continuing Activities -- Copyright -- Preface -- Contents -- Promise and Problems: Hib, Pneumococcal, and Meningococcal Vaccines in the Developing World -- INTRODUCTION -- ARI AND MENINGOCOCCAL MENINGITIS IN THE DEVELOPING WORLD -- DETERMINING VACCINE NEED -- OVERCOMING SCIENTIFIC AND TECHNOLOGICAL BARRIERS -- Pneumococcal Vaccines -- Meningococcal Vaccines -- PROVING VACCINE EFFICACY: THE CHALLENGE OF DEVELOPING-COUNTRY FIELD TRIALS -- The Public-/Private-Sector Interface -- INTRODUCING AN EFFECTIVE VACCINE -- Involving the U.S. Public and Private Sectors in the CVI -- INTRODUCTION -- BRINGING CLARITY TO THE CVI "VISION" -- TRENDS IN THE GLOBAL VACCINE SITUATION -- Industry Characteristics -- Local Production and Self-Sufficiency -- RESHAPING THE EPI -- A ROLE FOR INDUSTRY -- Barriers to Participation -- FACILITATING GREATER U.S. INVOLVEMENT -- Differential Pricing -- Technology Transfer -- DISCUSSION SUMMARY -- Appendix A Promise and Problems: Hib, Pneumococcal, and Meningococcal Vaccines in the Developing World -- FINAL AGENDA -- Day 1 -- Day 2 -- WORKSHOP SPEAKERS -- WORKSHOP PARTICIPANTS -- Staff -- Appendix B Involving the U.S. Public and Private Sectors in the CVI -- FINAL AGENDA -- Day 1 -- Involving the U.S. Public and Private Sectors in the CVI -- WORKSHOP SPEAKERS -- COMMISSIONED PAPER -- WORKSHOP PARTICIPANTS -- Staff -- Appendix C Acronyms and Abbreviations.